Skip to main content
. 2017 Apr 4;2017(4):CD000119. doi: 10.1002/14651858.CD000119.pub4

Aventis 2002.

Trial name or title An open‐label, randomised, parallel group, multicentre study to evaluate the efficacy and safety of enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism in people following acute ischaemic stroke
Methods  
Participants  
Interventions  
Outcomes  
Starting date  
Contact information Ms S Wellington, Senior Clinical Project Leader, Aventis Pharma, Aventis House, 50 Kings Hill Avenue, Kings Hill, West Malling, Kent, UK
Notes